Trial Profile
Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2008
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Sep 2008 New trial record.